other cells in the blood.
According to Langone, a Discover staff writer, doctors are only now beginning to explore uses of the new antibodies. Stanford researchers used monoclonals to push one California man's lymphatic cancer into remission in 1981. Johns Hopkins's Dr. Stanley Order has successfully injected patients with monoclonals bearing radioactive iodine to treat liver cancers. Because the monoclonals do not bind to normal cells, the patient avoids the side effects of conventional chemotherapy....